AVIR logo

Atea Pharmaceuticals (AVIR)

Profile

Full Name

Atea Pharmaceuticals, Inc.

Ticker Symbol

AVIR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 30, 2020

Indexes

Not included

Website

http://ateapharma.com

Employees

56

Key Details

Price

$3.03(+1.00%)

Market cap

$259.14M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.00(-22.70% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.03
AVIR price is $3.03

30-Day Relative Volume

1.91
AVIR 30-day relative volume is 1.91

Price Performance

Price Today change

+1%
AVIR price is up +1% today

Price YTD change

-9.55%
AVIR price is down -9.55% since January 1st

Price 1-year change

-18.33%
AVIR price is down -18.33% year-on-year

Price 3-year change

-54.02%
AVIR price is down -54.02% over the past 3 years

Price Range

Price All-time high

$94.17
AVIR price is currently -96.78% below its historical high of $94.17

Price 3-year low

$2.60
AVIR price is currently +16.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$259.14M
AVIR market capitalization is $259.14 million

Market cap 3-year change

-52.77%
AVIR market capitalization is down -52.77% over the past 3 years

Market cap All-time high

$7.29B
AVIR market capitalization is currently -96.45% below its historical high of $7.29 billion

Market cap sector rank

61.35%
AVIR market capitalization is higher than 61.35% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.55%
AVIR shares outstanding is up +1.55% year-on-year

Shares Outstanding 3-Year Change

+2.72%
AVIR shares outstanding is up +2.72% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.66
AVIR beta is 0.66

200-day SMA

$3.33
AVIR price is currently -8.98% below its 200-day simple moving average

50-day SMA

$3.01
AVIR price is currently +0.64% above its 50-day simple moving average

RSI

53.34
AVIR 14-day relative strength index is 53.34

Volume

1.91
AVIR 30-day relative volume is 1.91

ATR

$0.19
AVIR average true range is $0.19

10-day Historical Volatility

70.85%
AVIR 10-day historical volatility is 70.85%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
AVIR annual revenue value is unknown

Revenue Analysts estimate

-
AVIR annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
AVIR annual revenue 1-year change is unknown

Revenue Sector rank

-
AVIR annual revenue is unknown

EPS

EPS

-$2.00
AVIR annual earnings per share is -$2.00

EPS Analysts estimate

-$1.72
AVIR annual earnings per share is currently +16.56% higher than the consensus analysts' forecast

EPS 1-year change

-22.7%
AVIR annual earnings per share is down -22.7% year-on-year

EPS Sector rank

38.84%
AVIR annual earnings per share is higher than 38.84% of companies in Healthcare sector

Profit

Gross profit

-
AVIR annual gross profit value is unknown

Gross margin

-
AVIR annual gross profit margin value is unknown

Operating profit

-$192.95M
AVIR annual operating income is -$192.95 million

Operating margin

-
AVIR annual operating profit margin value is unknown

Net income

-$168.38M
AVIR annual net profit is -$168.38 million

Net margin

-
AVIR annual net profit margin value is unknown

Expenses

Total expenses

$192.95M
AVIR annual total expenses is $192.95 million

Operating expenses

$192.95M
AVIR annual total operating expenses is $192.95 million

Cost of goods sold

-
AVIR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$48.85M
AVIR annual SGA is $48.85 million

Depreciation and amortization

$416.00K
AVIR annual depreciation & amortization is $416.00 thousand

Interest expense

-
AVIR annual interest expense value is unknown

Income tax

$925.00K
AVIR annual income tax is $925.00 thousand

EBIT & EBITDA

EBIT

-$192.95M
AVIR annual earnings before interest & taxes is -$192.95 million

EBITDA

-$192.53M
AVIR annual EBITDA is -$192.53 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$464.67M
AVIR annual total assets is $464.67 million

Non current assets

$2.31M
AVIR annual long term assets is $2.31 million

Current assets

$462.36M
AVIR annual total current assets is $462.36 million

Cash and cash equivalents

$64.70M
AVIR annual cash & cash equivalents is $64.70 million

Accounts receivable

-
AVIR annual accounts receivable value is unknown

Inventory

-
AVIR annual inventory value is unknown

Liabilities

Total liabilities

$25.80M
AVIR annual total liabilities is $25.80 million

Long term liabilities

$7.20M
AVIR annual total long term liabilities is $7.20 million

Current liabilities

$18.60M
AVIR annual total current liabilities is $18.60 million

Accounts payable

$4.46M
AVIR annual accounts payable is $4.46 million

Debt

Total debt

$1.64M
AVIR annual total debt is $1.64 million

Total debt 1-year change

-31.64%
AVIR annual total debt is down -31.64% year-on-year

Long term debt

$842.00K
AVIR annual long term debt is $842.00 thousand

Short term debt

$800.00K
AVIR annual short term debt is $800.00 thousand

Equity & Capital

Shareholders equity

$438.87M
AVIR annual stockholders equity is $438.87 million

Book value

$438.87M
AVIR annual book value is $438.87 million

Retained earnings

-$364.22M
AVIR annual retained earnings is -$364.22 million

Working capital

$443.75M
AVIR annual working capital is $443.75 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$135.50M
AVIR annual cash flow from operations is -$135.50 million

Cash from operations 1-year change

-58.67%
AVIR annual cash flow from operations is down -58.67% year-on-year

Cash from investing

$56.10M
AVIR annual cash flow from investing activities is $56.10 million

Cash from investing 1-year change

+39.21%
AVIR annual cash flow from investing activities is up +39.21% year-on-year

Cash from financing

$267.00K
AVIR annual cash flow from financing activities is $267.00 thousand

Cash from financing 1-year change

+3.89%
AVIR annual cash flow from financing activities is up +3.89% year-on-year

CAPEX

CAPEX

-
AVIR annual capital expenditures value is unknown

CAPEX 1-year change

-
AVIR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$135.50M
AVIR annual free cash flow is -$135.50 million

Free cash flow 1-year change

-58.67%
AVIR annual free cash flow is down -58.67% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
AVIR annual gross profit margin value is unknown

Operating margin

-
AVIR annual operating profit margin value is unknown

Net margin

-
AVIR annual net profit margin value is unknown

ROA & ROE

ROA

-36.24%
AVIR annual return on assets is -36.24%

ROE

-38.37%
AVIR annual return on equity is -38.37%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AVIR price to earnings ratio value is unknown

PE ratio Sector rank

-
AVIR price to earnings ratio is unknown

PB Ratio

PB ratio

0.59
AVIR price to book ratio is 0.59

PB ratio Sector rank

33.03%
AVIR price to book ratio is higher than 33.03% of companies in Healthcare sector

PS Ratio

PS ratio

-
AVIR price to sales ratio value is unknown

PS ratio Sector rank

-
AVIR price to sales ratio is unknown

Enterprise value

Enterprise value

$196.09M
AVIR enterprise value is $196.09 million

Enterprise value Sector rank

59.37%
AVIR enterprise value is higher than 59.37% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.02
AVIR EV/EBITDA is -1.02

EV/EBITDA Sector rank

42.43%
AVIR EV/EBITDA is higher than 42.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

24.85
AVIR annual current ratio is 24.85

Quick ratio

-
AVIR annual quick ratio value is unknown

Leverage

Debt to equity

0.00
AVIR annual debt to equity ratio is 0.00

Interest coverage ratio

-
AVIR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
AVIR piotroski f-score value is unknown

Altman Z-Score

-
AVIR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 11, 25 Morgan Stanley
Equal-Weight
Aug 13, 24 Morgan Stanley
Equal-Weight
Aug 10, 23 JP Morgan
Underweight
Mar 16, 23 JP Morgan
Neutral
Jan 27, 23 SVB Leerink
Market Perform
Jan 24, 23 Morgan Stanley
Underweight
Aug 15, 22 Morgan Stanley
Underweight
Mar 2, 22 JP Morgan
Neutral
Mar 1, 22 SVB Leerink
Market Perform
Feb 16, 22 SVB Leerink
Market Perform

Institutional Ownership

Similar stocks

ZIMV logo
ZimVie (ZIMV)
SMTI logo
Sanara MedTech (SMTI)
VSTM logo
Verastem (VSTM)
VNDA logo
Vanda Pharmaceuticals (VNDA)
VMD logo
Viemed Healthcare (VMD)
TSVT logo
2seventy bio (TSVT)
EBS logo
Emergent BioSolutions (EBS)
HCAT logo
Health Catalyst (HCAT)
STIM logo
Neuronetics (STIM)
  • What is the ticker symbol for Atea Pharmaceuticals?
  • Does Atea Pharmaceuticals pay dividends?
  • What sector is Atea Pharmaceuticals in?
  • What industry is Atea Pharmaceuticals in?
  • What country is Atea Pharmaceuticals based in?
  • When did Atea Pharmaceuticals go public?
  • Is Atea Pharmaceuticals in the S&P 500?
  • Is Atea Pharmaceuticals in the NASDAQ 100?
  • Is Atea Pharmaceuticals in the Dow Jones?
  • When was Atea Pharmaceuticals's last earnings report?
  • When does Atea Pharmaceuticals report earnings?
  • Should I buy Atea Pharmaceuticals stock now?

What is the ticker symbol for Atea Pharmaceuticals?

The ticker symbol for Atea Pharmaceuticals is NASDAQ:AVIR

Does Atea Pharmaceuticals pay dividends?

No, Atea Pharmaceuticals does not pay dividends

What sector is Atea Pharmaceuticals in?

Atea Pharmaceuticals is in the Healthcare sector

What industry is Atea Pharmaceuticals in?

Atea Pharmaceuticals is in the Biotechnology industry

What country is Atea Pharmaceuticals based in?

Atea Pharmaceuticals is headquartered in United States

When did Atea Pharmaceuticals go public?

Atea Pharmaceuticals's initial public offering (IPO) was on October 30, 2020

Is Atea Pharmaceuticals in the S&P 500?

No, Atea Pharmaceuticals is not included in the S&P 500 index

Is Atea Pharmaceuticals in the NASDAQ 100?

No, Atea Pharmaceuticals is not included in the NASDAQ 100 index

Is Atea Pharmaceuticals in the Dow Jones?

No, Atea Pharmaceuticals is not included in the Dow Jones index

When was Atea Pharmaceuticals's last earnings report?

Atea Pharmaceuticals's most recent earnings report was on Mar 6, 2025

When does Atea Pharmaceuticals report earnings?

The next expected earnings date for Atea Pharmaceuticals is May 14, 2025

Should I buy Atea Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page